Literature DB >> 29311450

Evaluation of insulin resistance improvement after laparoscopic sleeve gastrectomy or gastric bypass surgery with HOMA-IR.

Yubing Zhu1, Zhipeng Sun1, Yanmin Du1, Guangzhong Xu1, Ke Gong1, Bin Zhu1, Nengwei Zhang1.   

Abstract

Our purpose was to explore the remission of insulin resistance after bariatric surgery to discover the mechanism of diabetes remission excluding dietary factors. A retrospective case control study was conducted on patients with type 2 diabetes, who underwent laparoscopic sleeve gastrectomy (LSG) or laparoscopic gastric bypass surgery (LGB) in Beijing Shijitan Hospital from April 1, 2012 to April 1, 2013. The laboratory and anthropometric data was analyzed pre-surgery and during a 2-year follow-up. HOMA-IR was calculated and evaluated. The two surgical procedures were compared. No significant difference in complete remission rate was observed between the two groups (LGB group: 62.1%, LSG group: 60.0%, p = 0.892). HOMA-IR was reduced to a stable level at the 3rd month after surgery. The cut-off value of HOMA-IR was 2.38 (sensitivity: 0.938, specificity: 0.75) and 2.33 (sensitivity: 0.941, specificity: 0.778) respectively for complete remission after LSG or LGB surgery. Insulin resistance was improved while GLP-1 and Ghrelin was changed significantly in patients with type 2 diabetes prior to weight loss either in the LSG or LGB group. HOMA-IR decreased to less than the cut-off value at the 3rd month and was closely related to complete remission. The mechanism of bariatric surgery was not due just to simply dietary factors or body weight loss but also the remission of insulin resistance.

Entities:  

Keywords:  Laparoscopic sleeve gastrectomy (LSG); homeostasis model of insulin resistance index (HOMA-IR); laparoscopic gastric bypass (LGB); type 2 diabetes

Mesh:

Year:  2017        PMID: 29311450     DOI: 10.5582/bst.2017.01307

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  5 in total

1.  Remission of Type 2 Diabetes and Sleeve Gastrectomy in Morbid Obesity: a Comparative Systematic Review and Meta-analysis.

Authors:  Ferdous Madadi; Rami Jawad; Ismail Mousati; Philip Plaeke; Guy Hubens
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

2.  Retrospective Comparison of SADI-S Versus RYGB in Chinese with Diabetes and BMI< 35kg/m2: a Propensity Score Adjustment Analysis.

Authors:  Qing Sang; Liang Wang; Qiqige Wuyun; Xuejing Zheng; Dezhong Wang; Nengwei Zhang; Dexiao Du
Journal:  Obes Surg       Date:  2021-09-30       Impact factor: 4.129

3.  Preintervention Clinical Determinants and Measured β-Cell Function As Predictors of Type 2 Diabetes Remission After Roux-en-Y Gastric Bypass Surgery.

Authors:  Chanel Ligon; Ankit Shah; Malini Prasad; Blandine Laferrère
Journal:  Diabetes Care       Date:  2021-08-15       Impact factor: 17.152

4.  Determinants of type 2 diabetes remission after bariatric surgery in obese Japanese patients: a retrospective cohort study.

Authors:  Masahiro Ohira; Yasuhiro Watanabe; Takashi Yamaguchi; Atsuhito Saiki; Shoko Nakamura; Shou Tanaka; Naomi Shimizu; Taiki Nabekura; Takashi Oshiro; Ichiro Tatsuno
Journal:  Diabetol Int       Date:  2021-01-28

5.  Evaluation of Lipoprotein Profile and Residual Risk Three Years After Bariatric Surgery.

Authors:  Elena González Arnáiz; María D Ballesteros Pomar; Lucía González Roza; Begoña Pintor de la Maza; Beatriz Ramos Bachiller; Diana Ariadel Cobo; Ana Urioste Fondo; Isidoro Cano Rodríguez
Journal:  Obes Surg       Date:  2021-07-10       Impact factor: 4.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.